CHI St. Luke’s Health–Baylor St. Luke’s Medical Center First Hospital to Use Digital Spyglass Technology
CHI St. Luke’s Health–Baylor St. Luke’s Medical Center (Baylor St. Luke’s) announced today that it’s the first hospital in the United States to perform endoscopic procedures using the new SpyGlass Digital System (DS).
Baylor St. Luke’s is home to the most active endoscopy unit in the country—having performed more endoscopic procedures using the SpyGlass technology than any other hospital.
“We’re honored to be the first facility to have access to this new digital system,” said Isaac Raijman, MD, Chief of Gastroenterology, Baylor St. Luke’s and the first physician to use SpyGlass DS. “While the original SpyGlass system helped improve overall efficiency and diagnosis, the new digital system enhances patient treatment and outcomes.” SpyGlass has served as a leading diagnostic and therapeutic endoscopy solution for the past decade.
SpyGlass DS, the digital successor to the SpyGlass Legacy System, is a single-operator device that allows physicians to directly visualize the pancreatico-bilary system through advanced digital imaging, rather than the pixelated fiber optic imaging used in the legacy model. In addition, the digital system has four times the resolution and a 60 percent wider field of view. With improved visualization and a greater reach, physicians can easily navigate through the pancreatico-bilary system to detect and treat biliary stones, biliary strictures (an abnormal narrowing of the common bile duct) and other abnormalities.
“Physicians can now deliver even more effective treatment in one procedure, thus improving patient care,” said Dr. Raijman. “With our expertise, Baylor St. Luke’s is committed to helping other physicians adopt this new technology to advance the treatment of biliary and pancreatic disease nationwide.”
Through weekly preceptorships, Dr. Raijman trains physicians, from the U.S and around the world, on how to diagnose patients using the SpyGlass technology.
